Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
May 29 (Reuters) - Genor Biopharma Holdings Ltd 6998.HK: NMPA GRANTED NEW DRUG APPLICATION APPROVAL FOR LEROCICLIB (GB491) Further company coverage: 6998.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: JHBP CY Says Chairman And CEO Ni Xin To Buy Shares Up To USD 1 Million From Aug 31, 2026
Brief: Edding Genor Group Expects Revenue Of RMB850 MLN-RMB900 MLN For HY
Brief: Jhbp Cy Disposal Of Equity Interest In Candid Therapeutics
Edding Genor climbs on approval of clinical trial of cancer drug in China
Brief: JHBP CY's Phase Ib/Ii Clinical Trial Of Gb268 Obtains IND Approval By NMPA